Browsing: pharmaceutical industry

Eli Lilly plans to invest billions to shift drug manufacturing to the U.S., aiming to strengthen domestic supply chains, boost production capacity and reduce reliance on overseas facilities.

President Donald Trump and nine major drugmakers have agreed to cut prices on select medications, aiming to ease costs for U.S. patients and address mounting public anger over drug pricing.

Donald Trump touted a breakthrough on lowering drug prices, but a closer look reveals pharmaceutical giants also benefited, raising questions about who truly gained from the policy shifts.

President Donald Trump and AstraZeneca unveiled a new US drug pricing deal at the White House, aiming to lower prescription costs and expand patient access, sources told Reuters.